228726-66-7Relevant academic research and scientific papers
The design and development of 2-aryl-2-hydroxy ethylamine substituted 1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamides as inhibitors of human cytomegalovirus polymerase
Tanis, Steven P.,Strohbach, Joseph W.,Parker, Timothy T.,Moon, Malcom W.,Thaisrivongs, Suvit,Perrault, William R.,Hopkins, Todd A.,Knechtel, Mary L.,Oien, Nancee L.,Wieber, Janet L.,Stephanski, Kevin J.,Wathen, Michael W.
scheme or table, p. 1994 - 2000 (2010/10/02)
Discovery efforts were focused on identifying a non-nucleoside antiviral for treating infections caused by human cytomegalovirus (HCMV) with equal or better potency and diminished toxicity compared to current therapeutics. This Letter describes the HCMV D
Quinolinecarboxamides as antiviral agents
-
, (2008/06/13)
The present invention provides a compound of formula I which is useful as antiviral agents, in particular, as agents against viruses of the herpes family.
4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
-
, (2008/06/13)
The present invention provides 4-hydroxyquinoline-3-carboxamide and hydrazide compounds of formula I These compounds are useful to treat or prevent the herpesviral infections, particularly, human cytomegaloviral infection.
